NewsRoom

The SURVIVEiT® NewsRoom provides patients with quick access to exclusive news, treatment breakthroughs, survivor stories, and expert interviews providing the latest insight about this rapidly evolving industry. Visit our NewsRoom often and follow us on Facebook.

Category: Breast Cancer

FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf for HER2-positive breast

June 30th, 2020
Read More
FDA approves tucatinib for patients with HER2-positive metastatic breast cancer

June 2nd, 2020
Read More
FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast

June 2nd, 2020
Read More
Breast Cancer News | Some Patients NED After New Combo

May 5th, 2020
Read More
FDA approves neratinib for metastatic HER2-positive breast cancer

February 27th, 2020
Read More
Regular Exercise Can Improve Quality of Life For Breast Cancer Patients

October 25th, 2019
Read More
How To Perform a Male Breast Exam Self-Check | Male Breast Cancer Awareness

October 15th, 2019
Read More
Link To Rare Cancer Causes Breast Implants To Be Recalled

October 10th, 2019
Read More
Real Thoughts That Cross A Breast Cancer Patient’s Mind

October 8th, 2019
Read More
FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC

August 19th, 2019
Read More
FDA approves Herzuma as a biosimilar to Herceptin (for breast cancer)

January 15th, 2019
Read More
FDA approves talazoparib for gBRCAm HER2-negative locally advanced or metastatic breast cancer

October 22nd, 2018
Read More
Study shows value of breast cancer patients seeking second opinions

September 28th, 2018
Read More
Lilly receives additional FDA approval for abemaciclib as ... treatment for advanced breast cancer

March 1st, 2018
Read More
FDA approves first treatment for breast cancer with a certain inherited genetic mutation

January 12th, 2018
Read More
A New Viral Therapy Eradicated The Most Untreatable Type of Breast Cancer in 90 Percent of Mice

January 4th, 2018
Read More
FDA Approves Second Biosimilar for Cancer (for stomach & breast)

December 6th, 2017
Read More
Faslodex receives US FDA approval for the treatment of advanced breast cancer in combination with ab

November 21st, 2017
Read More
New Trial for some NTRK, ALK and ROS1 patients.

October 30th, 2017
Read More
FDA approves abemaciclib for HR-positive, HER2-negative breast cancer

October 9th, 2017
Read More
Tibetan yoga practice may improve sleep quality for breast cancer patients receiving chemotherapy

September 28th, 2017
Read More
FDA Expands Approval of Fulvestrant for Advanced Breast Cancer

September 26th, 2017
Read More
Stage, ER Status Guide HER2 Therapy Selection in Breast Cancer

September 20th, 2017
Read More
Ipatasertib Improves PFS in Advanced Triple-Negative Breast Cancer

September 12th, 2017
Read More
New breast cancer drug is ‘very exciting’

September 11th, 2017
Read More
ESMO 2017: Study in early stage breast cancer shows that even small tumors can be aggressive

September 5th, 2017
Read More
Researchers Investigate Potential New Tool in Diagnosing Breast Cancer

August 14th, 2017
Read More
8 brain tumor treatment questions, answered

August 9th, 2017
Read More
FDA approves new treatment to reduce the risk of breast cancer returning

July 26th, 2017
Read More
FDA Approves Ribociclib, Expands Palbociclib Approval for Metastatic Breast Cancer

April 12th, 2017
Read More
Bowdens Seek Out the Best Care for Breast Cancer, and Find it at Avera

March 1st, 2017
Read More
Mecca for Metastatic Breast Cancer

November 26th, 2016
Read More